BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Drug Development

  CV Therapeutics, Inc. Release: Data From Evaluation Of Ranolazine In Chronic Angina (ERICA) Study Presented At American Heart Association Scientific Sessions 2005

  November 17, 2005

   · 

  5 min read
• Drug Development

  Biomira Inc. Release: BLP25 Liposome Vaccine Phase 2 Study Interim Results Indicate No Safety Concerns With Reformulated Vaccine

  November 17, 2005

   · 

  3 min read
• Business

  Smith & Nephew Endoscopy Appoints Executives To Lead Research And Development And Marketing Efforts

  November 17, 2005

   · 

  3 min read
• Biotech Bay

  AgraQuest, Inc. Receives EPA And CAL-EPA Registration Of Natural Fumigant Based On Muscodor Albus, A Safe, Effective Alternative For Methyl Bromide

  November 17, 2005

   · 

  3 min read
• Business

  CalbaTech, Inc.'s Subsidiary, LifeStem Inc., Signs Letter Of Intent To Offer Its Stem Cell MicroBank Collection Service Through Solana MedSpas

  November 17, 2005

   · 

  3 min read
• Drug Development

  Phase 2 Study Finds That Jazz Pharmaceuticals, Inc.'s Xyrem(R) Relieves Pain And Improves Functioning In Patients Suffering From Fibromyalgia

  November 17, 2005

   · 

  4 min read
• Biotech Beach

  Endocare, Inc. Announces Plan To Deploy Next Generation Cryoablation Technology For New Applications

  November 17, 2005

   · 

  4 min read
• Drug Development

  Ariad Pharmaceuticals, Inc. Announces Initial Results Of Phase 1b Clinical Trial Of Oral AP23573 In Patients With Relapsed And/Or Refractory Cancers

  November 17, 2005

   · 

  1 min read
• Policy

  Genesis Bioventures Announces CLIA Certification For Its Breast Cancer Diagnostic Company, Biomedical Diagnostics

  November 17, 2005

   · 

  3 min read
• Deals

  Corgentech, Inc. And AlgoRx Pharmaceuticals, Inc. To Mail Definitive Proxy For Proposed Merger

  November 17, 2005

   · 

  4 min read